7 Mistakes in Treatment-Resistant Depression

Slideshow

Raise the dose, augment, or switch? A new study suggests we may need to give antidepressants more time to be effective.

Related Videos
Experts on MDD.
Experts on MDD.
Postpartum depression and major depressive disorder in pregnant and postpartum women are severely underdiagnosed and undertreated. How can we more effectively help this patient population?
Related Content

Single-Dose Psilocybin for Treatment-Resistant Major Depression

October 2nd 2023

Blue Light Blockers: A Behavior Therapy for Mania

October 7th 2021

Psychiatry in the News: September 2023

September 29th 2023

Treating ‘Morally Objectionable’ Patients

September 27th 2021

FDA Approves First Oral Selective 5HT1A Receptor Agonist for MDD

September 29th 2023

Topline Phase 2 Data Support Efficacy, Tolerability, and Favorable Safety of Treatment for PTSD

September 26th 2023

Single-Dose Psilocybin for Treatment-Resistant Major Depression

October 2nd 2023

Blue Light Blockers: A Behavior Therapy for Mania

October 7th 2021

Psychiatry in the News: September 2023

September 29th 2023

Treating ‘Morally Objectionable’ Patients

September 27th 2021

FDA Approves First Oral Selective 5HT1A Receptor Agonist for MDD

September 29th 2023

Topline Phase 2 Data Support Efficacy, Tolerability, and Favorable Safety of Treatment for PTSD

September 26th 2023

Single-Dose Psilocybin for Treatment-Resistant Major Depression

October 2nd 2023

Blue Light Blockers: A Behavior Therapy for Mania

October 7th 2021

Psychiatry in the News: September 2023

September 29th 2023

Treating ‘Morally Objectionable’ Patients

September 27th 2021

FDA Approves First Oral Selective 5HT1A Receptor Agonist for MDD

September 29th 2023

Topline Phase 2 Data Support Efficacy, Tolerability, and Favorable Safety of Treatment for PTSD

September 26th 2023
© 2023 MJH Life Sciences

All rights reserved.